A Pilot Study of Topical Honey for the Treatment of Eczema
Completed
- Conditions
- EczemaSkin - Dermatological conditions
- Registration Number
- ACTRN12612000561886
- Lead Sponsor
- Medical Research Institute of New Zealand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Aged 16 or over at the time of enrolment
Eczema involving the upper limbs
Bilateral lesions, to allow comparison
Exclusion Criteria
Requirement for topical or systemic corticosteroids, as judged by treating doctor
Requirement for antibiotic therapy, as judged by treating doctor
Known or suspected allergy to honey or dressings
Any other condition which, at the investigators discretion, it is believed may present a safety risk or impact the feasibility of the study or the study results
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eczema severity assessed by Intensity component of SCORAD (SCORing Atopic Dermatitis) score[At baseline and at final visit after 2 weeks]
- Secondary Outcome Measures
Name Time Method Subjective assessment of itch severity, measured by visual analogue score (VAS)[At baseline and at final visit after 2 weeks];Eczema severity assessed by Three Item Severity (TIS) score, a validated scoring system which assesses eczema severity according to the degree of redness, swelling and scratches.[At baseline and at final visit after 2 weeks];Acceptability of honey therapy, measured by VAS[At final visit after 2 weeks]